Fructosamine oxidase: antagonists and inhibitors
CA 2344690 C · Owner: Glycox Corporation Limited · Inventors: Cooper, Garth James Smith; Baker, John Richard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of reducing the consequences of macrovascular and microvascular damage in a diabetic patient reliant upon the inhibition and/or antagonism of Fructosamine oxidase in the patient. Inhibition and/or antagonism can involve the use of copper chelating agents substrate analogues or hydrazine compounds.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 24, 1999 and granted March 22, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 24, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 24, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.